Literature DB >> 17805558

Impact of interleukin-6 on the glucose metabolic capacity in rat liver.

Bianca Lienenlüke1, Bruno Christ.   

Abstract

The acute phase reaction mediated by the proinflammatory cytokine IL6 initiates a number of metabolic changes in the liver, which may contribute to the pathogenesis of the septic shock during prolonged exposition. Here, the impact of IL6 on the hepatic glucose providing capacity was studied by monitoring glycogen degradation and the expression of the gluconeogenic phosphoenolpyruvate carboxykinase (PCK1) in rat livers during the daily feeding rhythm. Eight hours after i.p. injection of IL6, mRNA levels of alpha2-macroglobulin, a prominent acute phase reactant in rat liver, were elevated as shown by Northern blot analysis and in situ hybridization (ISH). PCK1 mRNA levels were decreased by IL6 to 50% of levels in untreated animals due to the reduction of PCK1 mRNA in the periportal zone of the liver as shown by ISH. PCK1 enzyme activity was not affected by IL6. Glycogen degradation was accelerated by IL6, which led to nearly complete depletion of glycogen pools in periportal areas 8 h after IL6 injection. This was very likely due to inhibition of glycogen pool replenishment. Thus, the depletion of glycogen stores in the liver might contribute to the impairment of hepatic glucose production during prolonged acute phase challenge.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805558     DOI: 10.1007/s00418-007-0327-1

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  32 in total

Review 1.  Functional specialization of different hepatocyte populations.

Authors:  K Jungermann; N Katz
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

2.  Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes.

Authors:  T Kanemaki; H Kitade; M Kaibori; K Sakitani; Y Hiramatsu; Y Kamiyama; S Ito; T Okumura
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

3.  Inhibition by recombinant human interleukin-6 of the glucagon-dependent induction of phosphoenolpyruvate carboxykinase and of the insulin-dependent induction of glucokinase gene expression in cultured rat hepatocytes: regulation of gene transcription and messenger RNA degradation.

Authors:  B Christ; A Nath; P C Heinrich; K Jungermann
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

Review 4.  Nutritional aspects of leukocytic cytokines.

Authors:  K C Klasing
Journal:  J Nutr       Date:  1988-12       Impact factor: 4.798

Review 5.  Alterations in carbohydrate metabolism during stress: a review of the literature.

Authors:  B A Mizock
Journal:  Am J Med       Date:  1995-01       Impact factor: 4.965

6.  Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.

Authors:  M B Sewer; D R Koop; E T Morgan
Journal:  Drug Metab Dispos       Date:  1996-04       Impact factor: 3.922

7.  Predominant localization of phosphoenolpyruvate carboxykinase mRNA in the periportal zone of rat liver parenchyma demonstrated by in situ hybridization.

Authors:  H Bartels; H Linnemann; K Jungermann
Journal:  FEBS Lett       Date:  1989-05-08       Impact factor: 4.124

Review 8.  Hepatocyte heterogeneity in the metabolism of carbohydrates.

Authors:  K Jungermann; R G Thurman
Journal:  Enzyme       Date:  1992

9.  Study of inhibition of induction of phosphoenolpyruvate carboxykinase by endotoxin with radial immunodiffusion.

Authors:  D F Rippe; L J Berry
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

10.  Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver.

Authors:  E T Morgan; K B Thomas; R Swanson; T Vales; J Hwang; K Wright
Journal:  Biochim Biophys Acta       Date:  1994-10-18
View more
  6 in total

Review 1.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

2.  IL-6 deficiency in mice neither impairs induction of metabolic genes in the liver nor affects blood glucose levels during fasting and moderately intense exercise.

Authors:  L Fritsche; M Hoene; R Lehmann; H Ellingsgaard; A M Hennige; A K Pohl; H U Häring; E D Schleicher; C Weigert
Journal:  Diabetologia       Date:  2010-04-22       Impact factor: 10.122

3.  Protective efficacy of combined trivalent inactivated ISA 71 oil adjuvant vaccine against avian influenza virus subtypes (H9N2 and H5N1) and Newcastle disease virus.

Authors:  Zeinab Mohamed Ali; Mervat Abd El Monaem Hassan; Hussein Ali Hussein; Basem Mohamed Ahmed; Ahmed Abd El-Ghany El Sanousi
Journal:  Vet World       Date:  2017-10-11

4.  Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses.

Authors:  Heba M El Naggar; Mohamed Sayed Madkour; Hussein Ali Hussein
Journal:  Vet World       Date:  2017-02-14

5.  Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice.

Authors:  David I Stapleton; Xianzhong Lau; Marcelo Flores; Jennifer Trieu; Stefan M Gehrig; Annabel Chee; Timur Naim; Gordon S Lynch; René Koopman
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

6.  miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy.

Authors:  Paulina Podkalicka; Olga Mucha; Katarzyna Kaziród; Krzysztof Szade; Jacek Stępniewski; Liudmyla Ivanishchuk; Hirofumi Hirao; Ewelina Pośpiech; Alicja Józkowicz; Jerzy W Kupiec-Weglinski; Józef Dulak; Agnieszka Łoboda
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.